Benjamin J. Samelson‐Jones

2.1k total citations
33 papers, 862 citations indexed

About

Benjamin J. Samelson‐Jones is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Benjamin J. Samelson‐Jones has authored 33 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 20 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in Benjamin J. Samelson‐Jones's work include Virus-based gene therapy research (19 papers), Hemophilia Treatment and Research (19 papers) and CAR-T cell therapy research (11 papers). Benjamin J. Samelson‐Jones is often cited by papers focused on Virus-based gene therapy research (19 papers), Hemophilia Treatment and Research (19 papers) and CAR-T cell therapy research (11 papers). Benjamin J. Samelson‐Jones collaborates with scholars based in United States, Australia and Canada. Benjamin J. Samelson‐Jones's co-authors include Valder R. Arruda, Lindsey A. George, Bhavya S. Doshi, Katherine A. High, John E.J. Rasko, Margaret V. Ragni, Xavier M. Anguela, Klaudia Kuranda, Federico Mingozzi and Jonathan D. Finn and has published in prestigious journals such as New England Journal of Medicine, Blood and PEDIATRICS.

In The Last Decade

Benjamin J. Samelson‐Jones

31 papers receiving 848 citations

Peers

Benjamin J. Samelson‐Jones
Wing Yen Wong United States
Nina Mitchell United States
Mariëtte Boon‐Spijker Netherlands
Simon V. van Reijmersdal Netherlands
Irene Gil-Fariña Germany
Francesca Ferrua Italy
Angela Rivers United States
Raisa Jofra Hernández Italy
Tatjana Kilo Australia
Immacolata Brigida Italy
Wing Yen Wong United States
Benjamin J. Samelson‐Jones
Citations per year, relative to Benjamin J. Samelson‐Jones Benjamin J. Samelson‐Jones (= 1×) peers Wing Yen Wong

Countries citing papers authored by Benjamin J. Samelson‐Jones

Since Specialization
Citations

This map shows the geographic impact of Benjamin J. Samelson‐Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Samelson‐Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Samelson‐Jones more than expected).

Fields of papers citing papers by Benjamin J. Samelson‐Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin J. Samelson‐Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Samelson‐Jones. The network helps show where Benjamin J. Samelson‐Jones may publish in the future.

Co-authorship network of co-authors of Benjamin J. Samelson‐Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin J. Samelson‐Jones. A scholar is included among the top collaborators of Benjamin J. Samelson‐Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin J. Samelson‐Jones. Benjamin J. Samelson‐Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doshi, Bhavya S., Robert J. Davidson, Wei Wang, et al.. (2025). Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies. Molecular Therapy. 33(7). 3073–3085. 2 indexed citations
2.
Small, Juliana C., Sarah McCague, Sabrina W. Yum, et al.. (2025). Real-world outcomes of delandistrogene moxeparvovec gene therapy: Motor outcomes and emerging safety concerns. Molecular Therapy. 34(1). 123–130.
3.
Rasko, John E.J., Benjamin J. Samelson‐Jones, Lindsey A. George, et al.. (2025). Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study. New England Journal of Medicine. 392(15). 1508–1517. 5 indexed citations
4.
Levy‐Mendelovich, Sarina, Einat Avishai, Benjamin J. Samelson‐Jones, et al.. (2024). A Novel Murine Model Enabling rAAV8-PC Gene Therapy for Severe Protein C Deficiency. International Journal of Molecular Sciences. 25(19). 10336–10336.
5.
Samelson‐Jones, Benjamin J., Bhavya S. Doshi, & Lindsey A. George. (2024). Coagulation factor VIII: biological basis of emerging hemophilia A therapies. Blood. 144(21). 2185–2197. 4 indexed citations
6.
Doshi, Bhavya S., Benjamin J. Samelson‐Jones, Timothy C. Nichols, et al.. (2024). AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of life. Molecular Therapy — Methods & Clinical Development. 32(1). 101205–101205. 7 indexed citations
7.
Valentino, Leonard A., Margareth C. Ozelo, Roland W. Herzog, et al.. (2023). A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?. Journal of Thrombosis and Haemostasis. 21(11). 3033–3044. 11 indexed citations
8.
Doshi, Bhavya S., Elinor Willis, Timothy C. Nichols, et al.. (2023). Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dog. Molecular Therapy — Methods & Clinical Development. 31. 101159–101159. 5 indexed citations
9.
Croteau, Stacy E., M. Elaine Eyster, Huyen Tran, et al.. (2022). Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011. Blood. 140(Supplement 1). 1899–1901. 5 indexed citations
10.
Padua, Horacio M., Anne Marie Cahill, Kamlesh Kukreja, et al.. (2022). Appendix to the Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions: Pediatric Considerations. Journal of Vascular and Interventional Radiology. 33(11). 1424–1431. 3 indexed citations
11.
Robinson, Mary, Lindsey A. George, Marcus E. Carr, et al.. (2021). Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX‐Padua. Journal of Thrombosis and Haemostasis. 19(5). 1212–1218. 22 indexed citations
12.
Samelson‐Jones, Benjamin J. & Valder R. Arruda. (2020). Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A. Frontiers in Immunology. 11. 618–618. 30 indexed citations
13.
George, Lindsey A., Margaret V. Ragni, John E.J. Rasko, et al.. (2020). Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B. Molecular Therapy. 28(9). 2073–2082. 149 indexed citations
14.
Samelson‐Jones, Benjamin J., Jonathan D. Finn, Patrícia Favaro, J. Fraser Wright, & Valder R. Arruda. (2020). Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates. Molecular Therapy — Methods & Clinical Development. 17. 1129–1138. 38 indexed citations
15.
Samelson‐Jones, Benjamin J., Jonathan D. Finn, Lindsey A. George, Rodney M. Camire, & Valder R. Arruda. (2019). Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity. JCI Insight. 4(14). 35 indexed citations
16.
Samelson‐Jones, Benjamin J., et al.. (2018). Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXa. Thrombosis Research. 170. 133–141. 6 indexed citations
17.
Samelson‐Jones, Benjamin J. & Valder R. Arruda. (2018). Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy. Molecular Therapy — Methods & Clinical Development. 12. 184–201. 42 indexed citations
18.
Samelson‐Jones, Benjamin J., Paula M. Kramer, Michael C. Chicka, William T. Gunning, & Michele P. Lambert. (2017). MYH9‐macrothrombocytopenia caused by a novel variant (E1421K) initially presenting as apparent neonatal alloimmune thrombocytopenia. Pediatric Blood & Cancer. 65(4). 2 indexed citations
19.
Arruda, Valder R., Bhavya S. Doshi, & Benjamin J. Samelson‐Jones. (2017). Novel approaches to hemophilia therapy: successes and challenges. Blood. 130(21). 2251–2256. 92 indexed citations
20.
Samelson‐Jones, Benjamin J., Julie M. Crudele, Benjamin J. Lee, et al.. (2016). Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models. JCI Insight. 1(16). e89371–e89371. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wing Yen Wong Breakdown of academic impact, for papers by Nina Mitchell Breakdown of academic impact, for papers by Mariëtte Boon‐Spijker Breakdown of academic impact, for papers by Simon V. van Reijmersdal Breakdown of academic impact, for papers by Irene Gil-Fariña Breakdown of academic impact, for papers by Francesca Ferrua Breakdown of academic impact, for papers by Angela Rivers Breakdown of academic impact, for papers by Raisa Jofra Hernández Breakdown of academic impact, for papers by Tatjana Kilo Breakdown of academic impact, for papers by Immacolata Brigida
Rankless by CCL
2026